Month: November 2020

UK based Stablepharma is delighted to announce that they have been awarded an Innovate UK Smart Grant to advance the development of their disruptive vaccine stabilisation technology, StablevaX™. “This is a very welcome endorsement of our innovative technology to thermally stabilise vaccines”, says Nick Child, Managing Director, Stablepharma Ltd. This innovative technology will enable vaccines […]

Stablepharma Ltd is delighted to announce that the StablevaX™ invention to thermally stabilise vaccines, has just been granted a patent by the USPTO in the United States of America. This is probably the companies most commercially important patent granted to date and now completes our portfolio of successful grants in 14 international jurisdictions. Nick Child, […]